Update on Telesurgery and Novel Robotic Systems
David M. Albala, MD, explores telesurgery, highlighting its technological advancements, ethical considerations, and clinical potential.
Read MoreDavid M. Albala, MD, is a Chief of Urology at Crouse Hospital in Syracuse, New York. Dr. Albala is considered a national and international authority in laparoscopic and robotic urological surgery. His clinical interests include minimally invasive treatments for benign prostatic hypertrophy (BPH), the use of fibrin sealants in surgery, and robotic urologic surgery.
Dr. Albala earned his medical degree at Michigan State University in East Lansing. He completed a residency in Surgery at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. He then completed a fellowship in Endourology at Washington University in St. Louis, Missouri. Under the direction of Ralph V. Clayman, Dr. Albala was part of the team that performed the first laparoscopic nephrectomy in humans.
Dr. Albala is a past White House Fellow (1995-1996), who acted as a special assistant to Federico Peña, Secretary of Transportation, on classified and unclassified public health related issues. He has been a visiting professor at numerous institutions across the United States as well as overseas in countries such as India, China, Iceland, Germany, France, Japan, Brazil, Australia, and Singapore. He has done operative demonstrations in over 32 countries and 23 states. Dr. Albala has over 215 publications in peer-reviewed journals and has authored 3 textbooks in endourology and 4 books in general urology. He is currently the Editor-in-Chief of the Journal of Robotic Surgery and serves on the editorial board for Current Opinions in Urology, Reviews in Urology, and Urology Index and Reviews. In addition, he serves as a reviewer for 8 other surgical journals. He is currently on the Board of Directors of the Large Urology Group Practice Association (LUGPA). Dr. Albala is also currently the Visiting Professor of Urology at SUNY Downstate Health Sciences University, College of Medicine. Dr. Albala has been identified (by a Stanford University-led study) as one of the top 2% of scientists in the world.
David M. Albala, MD | Aug 2025
David M. Albala, MD, explores telesurgery, highlighting its technological advancements, ethical considerations, and clinical potential.
Read MoreDavid M. Albala, MD | Jul 2025
David M. Albala, MD, explores surgical strategies and diagnostic tools for managing prostate cancer.
Read MoreDavid M. Albala, MD | May 2025
David M. Albala, MD, discusses PSMA PET imaging in clinical practice, emphasizing the disruptive technology in managing prostate cancer.
Read MoreA panel discusses intermittent versus continuous androgen deprivation therapy (ADT) and its impact on prostate cancer outcomes.
Read MoreA panel of experts from the IPCU conference in Vail, Colorado explores challenges in prostate cancer management.
Read More